The world’s most expensive medicine
The most expensive drug on the planet is Glybera. It’s famous for being the first gene therapy ever approved in Europe and for its eye-popping price tag of $1 million. But what we learned this year is that the drug, for a rare metabolic condition, has only ever been given once, due to concerns over its cost and how well it works. Instead of being a history-making start to the era of DNA replacement, Glybera is a complete bust for its creator, the gene-therapy startup called UniQure.
The Download: how to fight pandemics, and a top scientist turned-advisor
Plus: Humane's Ai Pin has been unveiled
The race to destroy PFAS, the forever chemicals
Scientists are showing these damaging compounds can be beat.
Capitalizing on machine learning with collaborative, structured enterprise tooling teams
Machine learning advances require an evolution of processes, tooling, and operations.
How scientists are being squeezed to take sides in the conflict between Israel and Palestine
Tensions over the war are flaring on social media—with real-life ramifications.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.